NOVOBIOTIC PHARMACEUTICALS, LLC

Basic Information

767C CONCORD AVE
CAMBRIDGE, MA, 02138-1068

Company Profile

n/a

Additional Details

Field Value
DUNS: 140692976
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 14


  1. Specific anti-TB compounds from uncultured bacteria

    Amount: $219,069.00

    DESCRIPTION provided by applicant The slow pace of antibiotic discovery is being outmatched by rapid acquisition of resistance by our pathogens The need is especially acute in the case of Mycobact ...

    SBIR Phase I 2015 Department of Health and Human Services National Institutes of Health
  2. Microbial symbionts of marine invertebrates for antibiotic discovery

    Amount: $224,356.00

    DESCRIPTION provided by applicant The overall goal of this project is to discover novel antibiotics to combat important drug resistant pathogens One effective countermeasure against such pathogens ...

    SBIR Phase I 2015 Department of Health and Human Services National Institutes of Health
  3. Preclinical development of teixobactin, a new antibiotic

    Amount: $749,698.00

    DESCRIPTION provided by applicant The long term goal of this program is to develop a novel antimicrobial teixobactin into a therapeutic for treating a wide range of infections caused by Gram posi ...

    SBIR Phase II 2015 Department of Health and Human Services National Institutes of Health
  4. Selective agents against C. difficile infection

    Amount: $597,402.00

    DESCRIPTION provided by applicant The overall goal of this project is to develop a selective antibiotic against Clostridium difficile the major agent responsible for antibiotic induced diarrhea an ...

    SBIR Phase I 2014 Department of Health and Human Services National Institutes of Health
  5. Drug Discovery from Slow Growing and Rare Microbial Species

    Amount: $2,967,717.00

    DESCRIPTION (provided by applicant): The overall goal of this project is to discover novel antibiotics to combat important drug-resistant pathogens. We are running out of treatment options for pathoge ...

    SBIR Phase II 2013 Department of Health and Human Services
  6. SBIR Phase I: Novel Antibiotics from Marine Animal-Microbe Symbioses

    Amount: $147,276.00

    This Small Business Innovation Research (SBIR) Phase I project will develop a new platform technology to exploit previously inaccessible microbial diversity to discover novel broad-spectrum antibiotic ...

    SBIR Phase I 2013 National Science Foundation
  7. Drug Discovery from Slow Growing and Rare Microbial Species

    Amount: $2,967,717.00

    DESCRIPTION provided by applicant The overall goal of this project is to discover novel antibiotics to combat important drug resistant pathogens We are running out of treatment options for pathoge ...

    SBIR Phase II 2013 Department of Health and Human Services National Institutes of Health
  8. UV-Based Approach for Accessing New Antibiotics

    Amount: $599,946.00

    DESCRIPTION (provided by applicant): The goal of this project is to discover novel antibiotics by activating the silent biosynthetic operons of Actinobacteria. Whole genome sequencing of many Actinoba ...

    SBIR Phase I 2012 Department of Health and Human Services
  9. Drug Discovery from Slow Growing and Rare Microbial Species

    Amount: $598,976.00

    DESCRIPTION (provided by applicant): Multidrug resistant organisms are increasingly prevalent in nosocomial and community settings. Novel antibiotics with new mechanisms of action are needed to combat ...

    SBIR Phase I 2010 Department of Health and Human Services
  10. Isolating novel fungi for antibiotic discovery

    Amount: $2,998,500.00

    DESCRIPTION (provided by applicant): The goal of this project is to discover and develop novel broad-spectrum antibiotics acting against critically important human pathogens. The unmet need is especia ...

    SBIR Phase II 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government